The enduring charm of the Bangalore Derby

  

 

When a Positive Isn’t Open and Shut

 

By Sharan Kumar

 

Cluster positives, contaminated water, and expert opinion shift the Shambala case from individual culpability to a broader environmental concern, testing how far strict liability should stretch in the face of scientific complexity.

 

The

Lamotrigine positive in Shambala’s Group 3 triumph has stirred the pot, and not gently. In racing, a positive test is usually treated like a fire alarm, loud, urgent, and rarely questioned. But what happens when the alarm keeps ringing in multiple rooms, and someone quietly points out that the wiring itself might be faulty?

 

There is no disputing the foundation on which racing is built. Strict liability is its spine. If a prohibited substance is detected, the trainer is responsible. No ifs, no buts, no philosophical detours. It is a rule designed for clarity, not comfort. Racing, after all, prefers clean lines to messy explanations.

 

Yet, occasionally, reality refuses to stay within the neat boundaries of a rulebook.

 

Lamotrigine is not exactly the poster boy of performance enhancement. It does not turn plodders into champions or sprinters into rockets. It is subtle, slow-building, and about as useful on race day as bringing a library card to a sprint. If anything, its effects are more likely to take the edge off than sharpen it. Which raises a rather inconvenient question: if someone were plotting mischief, would this really be their weapon of choice?

 

The answer, like most things in racing, may lie not in intent, but in environment.

 

Modern laboratories today can detect substances at levels so microscopic that even the substance might be surprised it has been found. At picogram thresholds, science does not just find a needle in a haystack, it finds a whisper in a hurricane. The problem is that while detection has become extraordinarily precise, interpretation has not always kept pace.

 

And then there is the stable.

 

Far from being a sterile, laboratory-grade facility, a racing yard is a bustling ecosystem. Horses, handlers, grooms, feed, water, equipment, all in constant interaction. Many stable staff come from backgrounds where pharmacology is not exactly dinner-table conversation. Add to that the reality that human medications, including those used for conditions like epilepsy, are part of everyday life, and the possibility of inadvertent transfer begins to look less like fiction and more like probability.

 

Now, just when one might have settled into the comfort of suspicion, along comes the twist.

 

Not one, not two, but five horses have tested positive for the same substance. And just to keep things interesting, a couple of them do not even belong to the same stable. At this point, the narrative begins to wobble. Either there is a remarkably coordinated and curiously ineffective doping conspiracy at work, or something far more ordinary, and far less sinister, is at play.

 

Enter the water.

 

Scientific analysis has indicated the presence of lamotrigine across multiple water sources connected to the racing environment, and expert opinion has reinforced what the data already suggests: contamination through water is not just possible, but probable. When the same substance appears in the system of multiple horses across different stables, and the same substance is found in the water they all depend on, coincidence quietly exits the room.

 

But the counter-question arrives just as swiftly, and with some force: if the water is indeed contaminated, why have only a handful of horses tested positive in an environment that houses hundreds?

 

It is a fair question. It is also, scientifically, not as conclusive as it sounds.

 

Exposure in such environments is rarely uniform. Not every horse drinks the same quantity of water, at the same time, or even from the same source. Detection itself is governed by timing, metabolism, and thresholds so fine that the difference between a positive and a negative may lie in a fraction rather than a factor. Add to that the reality that only a select number of horses are tested, and the statistic begins to lose its apparent simplicity.

 

In other words, five positives do not necessarily mean five exposures. They may simply be the five instances where exposure crossed an invisible scientific line.

 

One could be forgiven for wondering whether the horses were being prepared for a race or unwittingly participating in a large-scale, unintended pharmacological experiment.

 

This is the point where the narrative shifts, and quite decisively.

 

Because what this body of evidence does is not eliminate responsibility, but it does significantly dilute the suggestion of malafide intent. The presence of a prohibited substance remains a violation. The trainer, under strict liability, remains vicariously responsible. That much is beyond debate.

 

But responsibility, as experience repeatedly reminds us, is not the same as culpability.

 

If the source of the substance lies in a shared environmental factor, if multiple horses across unrelated stables are affected, if the drug offers no clear performance advantage, and if the levels detected are consistent with trace exposure, then the case begins to look less like deliberate administration and more like systemic contamination.

 

In such a scenario, to apply the rule without nuance would be to confuse presence with intent, and accountability with wrongdoing.

 

Racing prides itself on integrity. But integrity is not merely about enforcing rules; it is about enforcing them with intelligence.

 

The Shambala case, therefore, is not just about a positive test. It is about how the sport responds when science complicates certainty. Somewhere between molecule and motive lies the truth, and finding it will require more than a mechanical reading of the rulebook.

 

Because when five horses test positive for the same substance, across stables, and the same substance is found in the water they drink, the question is no longer simply who is responsible.